医薬品：標準から医療用までのカプセル形態。ハードゼラチン、HPMC、吸入用、膣用など、あらゆる治療ニーズに対応する形態を設計。
ニュートラシューティカル：消費者用の栄養補助食品向け形態。差別化を求めるサプリメントメーカー向けに作られたカプセルで、その成分は他社の追随を許しません。
リソースとサポート
Filter by:
Content Type
Over the last 25 years, UC‑II® undenatured type II collagen has redefined the joint health category since its introduction to the market. Backed by clinical evidence…
Capsugel® Enprotect® capsules offer robust gastro resistance and predictable intestinal release, without any coating. In this on-demand webinar, Matt Richardson, Ph.…
Oral delivery of glucagon-like peptide-1 (GLP-1) peptides has the potential to improve patient convenience and adherence, but gastrointestinal degradation and…
Dr Vincent Jannin considers the advantages of delivering biologic medications, including glucagon-like peptide-1s, via oral delivery and discusses the technological…
Targeting the distal small intestine, specifically the terminal ileum, remains one of the greatest challenges in oral drug delivery.
Innovation in oral formulation technologies has opened new avenues for the lifecycle management and patent protection of biologics. Technologies such as SNAC, LBFs,…
In this webinar, Lonza Capsugel teamed up with sustainability innovators from HowGood and Puredia to share how brands can translate sustainability into supply…
The success and adoption of oral GLP-1 RAs mark a shift in biologic drug delivery. Technologies such as permeation enhancers, LBFs, and enteric protection have made…
Healthcare systems are facing increasing pressure as record demand, an aging population, the burden of chronic disease, and economic inflation challenge clinics,…
Meeting consumers’ needs is the first priority for any successful business. For over-the-counter (OTC) medications and supplements, oral dosage forms have long been…
Advancing acid labile or sensitive APIs is often slowed by coating steps that add time and complexity. This webinar offers a concise, science led look at recent data…
Discover how next-generation capsule technologies, including Capsugel(R) Enprotect(R) capsules, are advancing targeted oral drug delivery, improving bioavailability,…
The capsule market is shifting due to the growing importance of ethics and sustainability in driving consumer behavior. The ethical spending market has shown…
Maximizing Productivity in Vegan and Vegetarian Capsules Filling
経口投与可能な生物学的モダリティを提供するには、複数の分野における専門知識が必要です。Lonza Capsugelの科学者と技術者は、誠実に取り組んでいます…
生物学的療法は慢性疾患や複雑な疾患の治療を変革してきましたが、多くの場合、その影響は非経口投与の必要性によって制限されています。
持続可能性は、当社のビジネス戦略と経営理念の中核をなすものです。
